Levon Abrahamyan

Dr. Levon Abrahamyan

Faculty of Veterinary Medicine, Université de Montréal, Montréal, Quebec, Canada
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2010 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
Levon AbrahamyanLevon Abrahamyan
Levon Abrahamyan
LCLaurent Chatel-Chaix
Laurent Chatel-Chaix
LALara Ajamian
Lara Ajamian
MMMiroslav P. Milev
Miroslav P. Milev
AMAnne Monette
Anne Monette
AMAndrew Mouland
Andrew Mouland
Human immunodeficiency virus type 1 (HIV-1) Gag selects for and mediates genomic RNA (vRNA) encapsidation into progeny virus particles. The host protein, Staufen1 interacts directly with Gag and is found in ribonucleoprotein (RNP) complexes containing vRNA, which provides evidence that Staufen1 plays a role in vRNA selection and encapsidation. In this work, we show that Staufen1, vRNA and Gag are found in the same RNP complex. These cellular and viral factors also colocalize in cells and constitute novel Staufen1 RNPs (SHRNPs) whose assembly is strictly dependent on HIV-1 expression. SHRNPs are distinct from stress granules and processing bodies, are preferentially formed during oxidative stress and are found to be in equilibrium with translating polysomes. Moreover, SHRNPs are stable, and the association between Staufen1 and vRNA was found to be evident in these and other types of RNPs. We demonstrate that following Staufen1 depletion, apparent supraphysiologic-sized SHRNP foci are formed in the cytoplasm and in which Gag, vRNA and the residual Staufen1 accumulate. The depletion of Staufen1 resulted in reduced Gag levels and deregulated the assembly of newly synthesized virions, which were found to contain several-fold increases in vRNA, Staufen1 and other cellular proteins. This work provides new evidence that Staufen1-containing HIV-1 RNPs preferentially form over other cellular silencing foci and are involved in assembly, localization and encapsidation of vRNA.

27 July 2006 in Traffic
Verified
Journal Article
Open access
PDF file
KLKathy Lévesque
Kathy Lévesque
MHMelanie Halvorsen
Melanie Halvorsen
Levon AbrahamyanLevon Abrahamyan
Levon Abrahamyan
LCLaurent Chatel‐Chaix
Laurent Chatel‐Chaix
VPViviane Poupon
Viviane Poupon
AMAndrew Mouland
Andrew Mouland
Few details are known about how the human immunodeficiency virus type 1 (HIV‐1) genomic RNA is trafficked in the cytoplasm. Part of this process is controlled by the activity of heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2). The role of hnRNP A2 during the expression of abona fideprovirus in HeLa cells is investigated in this study. Using immunofluorescence and fluorescencein situhybridization techniques, we show that knockdown of hnRNP A2 expression in HIV‐1‐expressing cells results in the rapid accumulation of HIV‐1 genomic RNA in a distinct, cytoplasmic space that corresponds to the microtubule‐organizing center (MTOC). The RNA exits in the nucleus and accumulates at the MTOC region as a result of hnRNP A2 knockdown even during the expression of a provirus harboring mutations in the hnRNP A2‐response element (A2RE), the expression of which results in nuclear retention of genomic RNA. We also demonstrate that hnRNP A2 expression is required for downstream trafficking of genomic RNA from the MTOC in the cytoplasm. Genomic RNA localization at the MTOC that was both the result of hnRNP A2 knockdown and the overexpression of Rab7‐interacting lysosomal protein had little effect on pr55Gagsynthesis but negatively influenced virus production and infectivity. These data indicate that altered HIV‐1 genomic RNA localization modulates viral assembly and that the MTOC serves as a central site to which HIV‐1 genomic RNA converges following its exit from the nucleus, with the host protein, hnRNP A2, playing a central role in taking it to and from this site in the cell.

27 March 2008 in RNA
Verified
Journal Article
Closed access
LALara Ajamian
Lara Ajamian
Levon AbrahamyanLevon Abrahamyan
Levon Abrahamyan
MMMiroslav Milev
Miroslav Milev
Pavel IvanovPavel Ivanov
Pavel Ivanov
AKAndreas E. Kulozik
Andreas E. Kulozik
AMAndrew Mouland
Andrew Mouland
The HIV-1 ribonucleoprotein (RNP) contains the major structural protein, pr55Gag, viral genomic RNA, as well as the host protein, Staufen1. In this report, we show that the nonsense-mediated decay (NMD) factor UPF1 is also a component of the HIV-1 RNP. We investigated the role of UPF1 in HIV-1-expressing cells. Depletion of UPF1 by siRNA resulted in a dramatic reduction in steady-state HIV-1 RNA and pr55Gag. Pr55Gag synthesis, but not the cognate genomic RNA, was efficiently rescued by expression of an siRNA-insensitive UPF1, demonstrating that UPF1 positively influences HIV-1 RNA translatability. Conversely, overexpression of UPF1 led to a dramatic up-regulation of HIV-1 expression at the RNA and protein synthesis levels. The effects of UPF1 on HIV-1 RNA stability were observed in the nucleus and cytoplasm and required ongoing translation. We also demonstrate that the effects exerted by UPF1 on HIV-1 expression were dependent on its ATPase activity, but were separable from its role in NMD and did not require interaction with UPF2.

1 January 2005 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
Levon AbrahamyanLevon Abrahamyan
Levon Abrahamyan
SMSamvel R. Mkrtchyan
Samvel R. Mkrtchyan
JBJames Binley
James Binley
MLMin Lu
Min Lu
GMGrigory B. Melikyan
Grigory B. Melikyan
FCFredric S. Cohen
Fredric S. Cohen
We previously conducted a phase I/II study using arterial infusions of ONYX-015 (dl1520), a replication-selective adenoviral vector, with E1b deleted, for patients with metastatic colorectal cancer. No dose-limiting toxicities occurred, but >90% of the patients experienced fever. The effects of temperature on the replication of dl1520 in normal and transformed cells had not been studied. Therefore, replication and cell viability assays were performed with a panel of nontransformed and transformed cell lines cultured at 37 and 39.5°C and treated with adenovirus type 5 (Ad5) or dl1520. Ad5-mediated cytolytic effects were inhibited and production of infectious particles decreased by >1,000-fold in the nontransformed cells at 39.5°C. Seven of nine of the tumor cell lines retained significant cell-killing effects when treated with Ad5 at 39.5°C. When dl1520 was used, no cytolytic effects were observed at 39.5°C in the nontransformed cell lines; however, cytolytic effects occurred in six of nine tumor cell lines at 39.5°C. Notably, a subset of the tumor cell lines demonstrated increased dl1520-mediated cytolytic effect and replication at 39.5°C. Suppression of Ad5 and dl1520 replication at 39.5°C was not related to p53 status or HSP70 expression. Also, at 39.5°C, E1a expression was inhibited in nontransformed cells but was still abundant in the transformed cells, indicating that a novel early block in viral replication occurred in the nontransformed cells. Fever may therefore augment the therapeutic index of oncolytic viruses by inhibiting replication in normal cells while permitting or enhancing viral replication in some tumor cells.

3 June 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
GMGregory B. Melikyan
Gregory B. Melikyan
RBRichard J. O. Barnard
Richard J. O. Barnard
Levon AbrahamyanLevon Abrahamyan
Levon Abrahamyan
WMWalther Mothes
Walther Mothes
JYJohn A. T. Young
John A. T. Young
Viral fusion proteins catalyze merger of viral and cell membranes through a series of steps that have not yet been well defined. To elucidate the mechanism of virus entry, we have imaged fusion between single virions bearing avian sarcoma and leukosis virus (ASLV) envelope glycoprotein (Env) and the cell membrane. Viral particles were labeled with a lipophilic dye and with palmitylated enhanced YFP that was incorporated into the inner leaflet of the viral membrane. When individual virions were bound to target cells expressing cognate receptors, they transferred their lipids and contents only when exposed to low, but not neutral, pH. These data are consistent with the proposed two-step mechanism of ASLV entry that involves receptor-priming followed by low pH activation. Most importantly, lipid mixing commonly occurred before formation of a small fusion pore that was quickly and sensitively detected by pH-dependent changes in palmitylated enhanced YFP fluorescence. Nascent fusion pores were metastable and irreversibly closed, remained small, or fully enlarged, permitting nucleocapsid delivery into the cytosol. These findings strongly imply that hemifusion and a small pore are the key intermediates of ASLV fusion. When added before low pH treatment, a peptide designed to prevent Env from folding into a final helical-bundle conformation abolished virus-cell fusion and infection. Therefore, we conclude that, after receptor-activation, Env undergoes low pH-dependent refolding into a six-helix bundle and, in doing so, sequentially catalyzes hemifusion, fusion pore opening, and enlargement.

1 May 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MLMartin Lehmann
Martin Lehmann
MMMiroslav P. Milev
Miroslav P. Milev
Levon AbrahamyanLevon Abrahamyan
Levon Abrahamyan
XYXiao-Jian Yao
Xiao-Jian Yao
NPNelly Pante
Nelly Pante
AMAndrew Mouland
Andrew Mouland
Our earlier work indicated that the human immunodeficiency virus type 1 (HIV-1) genomic RNA (vRNA) is trafficked to the microtubule-organizing center (MTOC) when heterogeneous nuclear ribonucleoprotein A2/B1 is depleted from cells. Also, Rab7-interacting lysosomal protein promoted dynein motor complex, late endosome and vRNA clustering at the MTOC suggesting that the dynein motor and late endosomes were involved in vRNA trafficking. To investigate the role of the dynein motor in vRNA trafficking, dynein motor function was disrupted by small interference RNA-mediated depletion of the dynein heavy chain or by p50/dynamitin overexpression. These treatments led to a marked relocalization of vRNA and viral structural protein Gag to the cell periphery with late endosomes and a severalfold increase in HIV-1 production. In contrast, rerouting vRNA to the MTOC reduced virus production. vRNA localization depended on Gag membrane association as shown using both myristoylation and Gag nucleocapsid domain proviral mutants. Furthermore, the cytoplasmic localization of vRNA and Gag was not attributable to intracellular or internalized endocytosed virus particles. Our results demonstrate that dynein motor function is important for regulating Gag and vRNA egress on endosomal membranes in the cytoplasm to directly impact on viral production.